powered by: Cookie Information This website uses cookies Xellia Pharmaceuticals ApS uses strictly necessary cookies to make this website work. Xellia and third parties would also like to set optional cookies to improve the user experience as well as for statistics and targeted marketing. By clicking ‘Accept all’, you consent to the use of all cookies. You may always withdraw any given consent by clicking on the round icon in the left corner of the website. To learn more about Xellia’s use of Cookies please read our Cookie Policy, and if you want to know more about how Xellia processes personal data in relation to website visitors please read our Privacy Policy. DECLINE ALL ACCEPT ALL Strictly necessary Strictly necessary cookies help make a website navigable by activating basic functions such as page navigation and access to secure website areas. Without these cookies, the website would not be able to work properly. Functional Functional cookies make it possible to save information that changes the way the website appears or acts. For instance your preferred language or region. Statistical Statistical cookies help the website owner understand how visitors interact with the website by collecting and reporting information. Marketing Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and interesting to the individual user and thus more valuable for publishers and third-party advertisers. Unclassified We are in the process of classifying unclassified cookies together with the providers of the individual cookies. Strictly necessary Functional Statistical Marketing Novel anti-infective treatments Xellia is a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections.